继发性甲状旁腺功能亢进患者术前心功能评估
摘要
<正>继发性甲状旁腺功能亢进(secondary hyperparathyroidism,SHPT)是慢性肾功能不全患者长期透析的常见并发症。长期依赖透析的患者,会出现多系统并发症~([1～3]),尤以心血管疾病最为危险。慢性肾病(chronic kidney disease,
引文
[1] Webster AC,Nagler E,Morton RM,et al.Chronic kidney disease[J].Lancet,2016,389:1238-1252.
[2] Papademetriou V,Lovato L,Doumas M,et al.Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes[J].Kidney Int,2015,87:649-659.
[3] Reinecke H,Nabauer M,Gerth A,et al.Morbidity and treatment in patients with atrial fibrillation and chronic kidney disease[J].Kidney Int,2015,87:200-209.
[4] Collins AJ,Foley RN,Gilbertson DT,et al.United States renal data system public health surveillance of chronic kidney disease and end-stage renal disease[J].Kidney Int Suppl(2011),2015,5(1):2-7.
[5] Masakane I,Nakai S,Ogata S,et al.An overview of reg ular dialysis treatment in Japan(As of 31 December 2013)[J].Ther Apher Dial,2015,19(6):540-574.
[6] Go AS.Cardiovascular disease consequences of CKD[J].Semin Nephrol,2016,36:293-304.
[7] Ronco C.The cardiorenal syndrome:basis and common ground for a multidisciplinary patient-oriented therapy[J].Cardiorenal Med,2011,1:3-4.
[8] Fanari Z,Hammami S,Hammami MB,et al.Vitamin D deficiency plays an important role in cardiac disease and affects patient outcome:Still a myth or a fact that needs exploration?[J].Saudi Heart Assoc,2015,27:264-271.
[9] Toussaint ND,Damasiewicz MJ.Do the benefits of using calcitriol and other vitamin D receptor activators in patients with chronic kidney disease outweigh the harms?[J].Nephrology,2017,22:51-56.
[10] Taniguchi M,Fukagawa M,Fujii N,et al.Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients[J].Ther ApherDial,2013,17:221-228.
[11] Di Lullo L,House A,Gorini A,et al.Chronic kidney disease and cardiovascular complications[J].Heart Fail Rev,2015,20:259-272.
[12]王国华,章旭.慢性肾病患者甲状旁腺功能亢进与心血管疾病关系的研究进展[J].实用医学杂志,2011,27(23):4332-4334.
[13] Wang S,Qin L,Wu T,et al.Elevated cardiac markers in chronic kidney disease as a consequence of hyperphosphatemia induced cardiac myocyte injury[J].Medical Science Monitor,2014,20:2043-2053.
[14] Bansal N,Keane M,Delafontaine P,et al.CRIC study investigators:A longitudinal study of left ventricular function and structure from CKD to ESRD:the CRIC study[J].Clin J Am Soc Nephrol,2013,8:355-362.
[15] Chen SC,Chang JM,Liu WC,et al.Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease[J].Clin J Am Soc Nephrol,2012,27:1064-1070.
[16] DeVriese AS,Vandecasteele SJ,Vanden Bergh B,et al.Should we screen for coronary artery disease in asymptomatic chronic dialysis patients?[J].Kidney Int,2012,81:143-151.
[17] Rutledge MR,Farah V,Adeboye AA,et al.Parathyroid hormone,a crucial mediator of pathologic cardiac remodeling in aldosteronism[J].Cardiovasc Drugs Ther,2013,27:161-170.
[18] Flatt DM,Brown MC,Mizeracki AM,et al.Mineralocorticoid receptor antagonists in the management of heart failure and resistant hypertension:a review[J].JAMA Cardiol,2016,1:607-612.
[19]蔡威巍,徐树人,于颖吉,等.维持性血液透析患者血浆同型半胱氨酸和血清脑钠肽检测的临床意义[J].临床肾脏病杂志,2014,14(10):603-607.
[20]唐利,廖常彬,种春梅.血清脑钠肽及氨基末端脑钠肽前体在评价慢性肾衰竭患者心功能中的价值[J].临床肾脏病杂志,2016,164:215-218.
[21] Mishra RK,Li Y,Ricardo AC,et al.Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease(from the chronic renal insufficiency cohort[CRIC])[J].Am J Cardiol,2013,111:432-438.
[22] Stacy SR,Suarez-Cuervo C,Berger Z,et al.Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome:a systematic review[J].Ann Intern Med,2014,161:502-512.
[23] Michos ED,Wilson LM,Yeh HC,et al.Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome:a systematic review and meta-analysis[J].Ann Intern Med,2014,161:491-501.
[24] Huang JC,Wei SY,Chen SC,et al.P wave dispersion and maximum p wave duration are associated with renal outcomes in chronic kidney disease[J].PloS One,2014,9:e101962.
[25] Magnani JW,Johnson VM,Sullivan LM,et al.P wave duration and risk of longitudinal atrial fibrillation in persons≧60 years old(from the framingham heart study)[J].Am J Cardiol,2011,107:917-921.
[26] Kim SJ,Han SH,Park JT,et al.Left atrial volume is an independent predictor of mortality in CAPD patients[J].Nephrol Dial Transplant,2011,26:3732-3739.
[27] Stather PW,Sidloff D,Dattani N,et al.Systematic review and meta-analysis of the early and late outcomes of open and endovascular repair of abdominal aortic aneurysm[J].Br J Surg,2013,100:863-872.
[28] Paravastu SC,Jayarajasingam R,Cottam R,et al.Endovascular repair of abdominal aortic aneurysm[J].Cochrane Database Syst Rev,2014,1:CD004178.
[29] Wang CL,Qu G,Xu HW.The short-and long-term outcomes of laparoscopic versus open surgery for colorectal cancer:a meta-analysis[J].Int J Colorectal Dis,2014,29:309-320.
[30] Rosenmüller MH,Thorén rnberg M,Myrns T,et al.Expertise-based randomized clinical trial of laparoscopic versus small-incision open cholecystectomy[J].Br J Surg,2013,100:886-894.
[2] Papademetriou V,Lovato L,Doumas M,et al.Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes[J].Kidney Int,2015,87:649-659.
[3] Reinecke H,Nabauer M,Gerth A,et al.Morbidity and treatment in patients with atrial fibrillation and chronic kidney disease[J].Kidney Int,2015,87:200-209.
[4] Collins AJ,Foley RN,Gilbertson DT,et al.United States renal data system public health surveillance of chronic kidney disease and end-stage renal disease[J].Kidney Int Suppl(2011),2015,5(1):2-7.
[5] Masakane I,Nakai S,Ogata S,et al.An overview of reg ular dialysis treatment in Japan(As of 31 December 2013)[J].Ther Apher Dial,2015,19(6):540-574.
[6] Go AS.Cardiovascular disease consequences of CKD[J].Semin Nephrol,2016,36:293-304.
[7] Ronco C.The cardiorenal syndrome:basis and common ground for a multidisciplinary patient-oriented therapy[J].Cardiorenal Med,2011,1:3-4.
[8] Fanari Z,Hammami S,Hammami MB,et al.Vitamin D deficiency plays an important role in cardiac disease and affects patient outcome:Still a myth or a fact that needs exploration?[J].Saudi Heart Assoc,2015,27:264-271.
[9] Toussaint ND,Damasiewicz MJ.Do the benefits of using calcitriol and other vitamin D receptor activators in patients with chronic kidney disease outweigh the harms?[J].Nephrology,2017,22:51-56.
[10] Taniguchi M,Fukagawa M,Fujii N,et al.Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients[J].Ther ApherDial,2013,17:221-228.
[11] Di Lullo L,House A,Gorini A,et al.Chronic kidney disease and cardiovascular complications[J].Heart Fail Rev,2015,20:259-272.
[12]王国华,章旭.慢性肾病患者甲状旁腺功能亢进与心血管疾病关系的研究进展[J].实用医学杂志,2011,27(23):4332-4334.
[13] Wang S,Qin L,Wu T,et al.Elevated cardiac markers in chronic kidney disease as a consequence of hyperphosphatemia induced cardiac myocyte injury[J].Medical Science Monitor,2014,20:2043-2053.
[14] Bansal N,Keane M,Delafontaine P,et al.CRIC study investigators:A longitudinal study of left ventricular function and structure from CKD to ESRD:the CRIC study[J].Clin J Am Soc Nephrol,2013,8:355-362.
[15] Chen SC,Chang JM,Liu WC,et al.Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease[J].Clin J Am Soc Nephrol,2012,27:1064-1070.
[16] DeVriese AS,Vandecasteele SJ,Vanden Bergh B,et al.Should we screen for coronary artery disease in asymptomatic chronic dialysis patients?[J].Kidney Int,2012,81:143-151.
[17] Rutledge MR,Farah V,Adeboye AA,et al.Parathyroid hormone,a crucial mediator of pathologic cardiac remodeling in aldosteronism[J].Cardiovasc Drugs Ther,2013,27:161-170.
[18] Flatt DM,Brown MC,Mizeracki AM,et al.Mineralocorticoid receptor antagonists in the management of heart failure and resistant hypertension:a review[J].JAMA Cardiol,2016,1:607-612.
[19]蔡威巍,徐树人,于颖吉,等.维持性血液透析患者血浆同型半胱氨酸和血清脑钠肽检测的临床意义[J].临床肾脏病杂志,2014,14(10):603-607.
[20]唐利,廖常彬,种春梅.血清脑钠肽及氨基末端脑钠肽前体在评价慢性肾衰竭患者心功能中的价值[J].临床肾脏病杂志,2016,164:215-218.
[21] Mishra RK,Li Y,Ricardo AC,et al.Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease(from the chronic renal insufficiency cohort[CRIC])[J].Am J Cardiol,2013,111:432-438.
[22] Stacy SR,Suarez-Cuervo C,Berger Z,et al.Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome:a systematic review[J].Ann Intern Med,2014,161:502-512.
[23] Michos ED,Wilson LM,Yeh HC,et al.Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome:a systematic review and meta-analysis[J].Ann Intern Med,2014,161:491-501.
[24] Huang JC,Wei SY,Chen SC,et al.P wave dispersion and maximum p wave duration are associated with renal outcomes in chronic kidney disease[J].PloS One,2014,9:e101962.
[25] Magnani JW,Johnson VM,Sullivan LM,et al.P wave duration and risk of longitudinal atrial fibrillation in persons≧60 years old(from the framingham heart study)[J].Am J Cardiol,2011,107:917-921.
[26] Kim SJ,Han SH,Park JT,et al.Left atrial volume is an independent predictor of mortality in CAPD patients[J].Nephrol Dial Transplant,2011,26:3732-3739.
[27] Stather PW,Sidloff D,Dattani N,et al.Systematic review and meta-analysis of the early and late outcomes of open and endovascular repair of abdominal aortic aneurysm[J].Br J Surg,2013,100:863-872.
[28] Paravastu SC,Jayarajasingam R,Cottam R,et al.Endovascular repair of abdominal aortic aneurysm[J].Cochrane Database Syst Rev,2014,1:CD004178.
[29] Wang CL,Qu G,Xu HW.The short-and long-term outcomes of laparoscopic versus open surgery for colorectal cancer:a meta-analysis[J].Int J Colorectal Dis,2014,29:309-320.
[30] Rosenmüller MH,Thorén rnberg M,Myrns T,et al.Expertise-based randomized clinical trial of laparoscopic versus small-incision open cholecystectomy[J].Br J Surg,2013,100:886-894.